glp 1 alzheimer's 2024 Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders GLP-1 and Neuroscience: Reward, Addiction,

Behavioral strategies proven effective for weight maintenance include consistent self-monitoring of weight (at least weekly), food logging, regular meal patterns, and cognitive behavioral techniques to address emotional eating and environmental triggers

Fiber considerations for semaglutide (Ozempic, Wegovy) Semaglutide is the most widely prescribed GLP-1 receptor agonist, and its side effect profile is well documented

Weight loss is not a side effect but the primary endpoint

Pharmacological interventions are more limited, with antidepressants such as duloxetine (a serotonin-noradrenaline reuptake inhibitor) or amitriptyline (a tricyclic antidepressant) sometimes considered

A recent report from PwC UK suggests millions more people could start using them over the next few years, with knock-on effects for food, drink, retail, fitness and hospitality